Mirum to Host Call Sharing EXPAND Phase 3 Topline Results
Mirum Pharmaceuticals said it will host an investor call on October 12, 2026, at 8:30 a.m. ET to share topline results from its Phase 3 EXPAND study of LIVMARLI.
Mirum Pharmaceuticals said it will host an investor call on October 12, 2026, at 8:30 a.m. ET to share topline results from its Phase 3 EXPAND study of LIVMARLI.